| Literature DB >> 33222924 |
Nima Alan1, Song Kim2, Nitin Agarwal3, Jamie Clarke3, Donald M Yealy4, Aaron A Cohen-Gadol5, Raymond F Sekula3.
Abstract
We sought to evaluate feasibility and cost-reduction potential of a pilot screening program involving neurosurgeon tele-consultation for inter-facility transfer decisions in TBI patients with GCS 14-15 and abnormal CT head at a community hospital. The authors performed a retrospective comparative analysis of two patient cohorts during the pilot at a large hospital system from 2015 to 2017. In "screened" patients (n = 85), images and examination were reviewed remotely by a neurosurgeon who made recommendations regarding transfer to a level 1 trauma center. In the "unscreened" group (n = 39), all patients were transferred. Baseline patient characteristics, outcomes, and costs were reviewed. Patient demographics were similar between cohorts. Traumatic subarachnoid hemorrhage was more common in screened patients (29.4% vs 12.8%, P = 0.02). The presence of midline shift >5 mm was comparable between groups. Among screened patients, 5 were transferred (5.8%) and one required evacuation of chronic subdural hematoma. In unscreened patients, 7 required evacuation of subdural hematoma. None of the screened patients who were not transferred deteriorated. Screened patients had significantly reduced average total cost compared to unscreened patients ($2,003 vs. $4,482, P = 0.03) despite similar lengths of stay (2.6 vs. 2.7 days, P = 0.85). In non-surgical patients, costs were less in the screened group ($2,025 vs. $2,939), although statistically insignificant (P = 0.38). In this pilot study, remote review of images and examination by a neurosurgeon was feasible to avoid unnecessary transfer of patients with traumatic intracranial hemorrhage and GCS 14-15. The true potential in cost-reduction will be realized in system-wide large-scale implementation.Entities:
Keywords: Head trauma; Neurosurgery; TBI; Telemedicine; Transfer
Mesh:
Year: 2020 PMID: 33222924 PMCID: PMC7560640 DOI: 10.1016/j.jocn.2020.09.050
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961
Baseline patient characteristics and radiographic findings of all patients.
| Screened (n = 85) | Unscreened (n = 39) | P value | |
|---|---|---|---|
| Age (years, SD) | 81.2 (12.9) | 75.1 (16.9) | 0.05 |
| Age ≥ 65 y (%) | 77 (90.6) | 30 (76.9) | 0.07 |
| Sex (Male, %) | 33 (38.8) | 21 (53.8) | 0.12 |
| Aspirin (%) | 39 (45.9) | 17 (43.4) | 0.81 |
| Plavix (%) | 8 (9.4) | 9 (23.1) | 0.07 |
| Coumadin (%) | 15 (17.6) | 9 (23.1) | 0.49 |
| Other anticoagulant (%) | 5 (5.9) | 1 (2.7) | 0.36 |
| Fall | 77 (90.6) | 30 (76.9) | 0.07 |
| MVA | 1 (1.2) | 2 (5.1) | 0.23 |
| Assault | 0 (0.0) | 1 (2.6) | 0.32 |
| Unknown | 7 (8.2) | 6 (15.4) | 0.34 |
| GCS 15 | 80 (94.1) | 32 (82.1) | 0.07 |
| GCS 14 | 5 (5.9) | 7 (17.9) | 0.07 |
| Subdural | 48 (56.5) | 29 (74.4) | |
| Subarachnoid | 25 (29.4) | 5 (12.8) | |
| Intraparenchymal | 3 (3.5) | 0 (0.0) | 0.55 |
| Intraventricular | 0 (0.0) | 2 (5.1) | 0.10 |
| Multicompartmental | 2 (2.3) | 3 (7.7) | 0.24 |
| Present (any size) | 9 (10.9) | 11 (28.2) | |
| ≥5 mm | 3 (3.5) | 4 (10.3) | 0.21 |
| Surgery | 1 (1.2) | 7 (17.9) | |
| No surgery | 84 (98.8) | 32 (82.1) | |
| LOS (days, SD) | 2.6 (3.3) | 2.7 (1.9) | 0.85 |
Denotes statistically significant difference. SD = standard deviation, MVA = motor vehicle accident, MLS = midline shift, GCS = Glasgow Coma Scale, LOS = length of stay.
Baseline patient characteristics and radiographic findings of patients that did not have surgical intervention.
| Screened (n = 83) | Unscreened (n = 32) | P value | |
|---|---|---|---|
| Age (years, SD) | 81.2 (13.0) | 74.8 (18.1) | 0.07 |
| Age ≥ 65 y (%) | 76 (90.5) | 24 (75.0) | 0.06 |
| Sex (Male, %) | 33 (39.3) | 17 (53.1) | 0.18 |
| Aspirin (%) | 38 (45.2) | 14 (43.8) | 0.89 |
| Plavix (%) | 8 (9.5) | 8 (25.0) | 0.06 |
| Coumadin (%) | 15 (17.9) | 8 (25.0) | 0.41 |
| Other anticoagulant (%) | 5 (6.0) | 1 (3.1) | 0.48 |
| Fall | 76 (90.5) | 23 (71.9) | |
| MVA | 1 (1.2) | 2 (6.3) | 0.18 |
| Assault | 0 (0.0) | 1 (3.1) | 0.28 |
| Unknown | 6 (7.1) | 6 (18.8) | 0.13 |
| Traumatic injury | 5 (6.0) | 4 (12.5) | 0.26 |
| GCS 15 | 80 (95.2) | 27 (84.4) | 0.11 |
| GCS 14 | 4 (4.8) | 5 (15.6) | 0.11 |
| Subdural | 47 (56.0) | 23 (71.9) | 0.10 |
| Subarachnoid | 30 (35.7) | 5 (15.6) | |
| Intraparenchymal | 3 (3.6) | 0 (0.0) | 0.56 |
| Intraventricular | 2 (2.4) | 1 (3.1) | 1.00 |
| Multicompartmental | 2 (2.4) | 3 (9.4) | 0.13 |
| Present (any size) | 8 (9.5) | 6 (18.8) | 0.23 |
| ≥5 mm | 3 (3.6) | 1 (3.1) | 1.00 |
| LOS (days, SD) | 2.62 (3.38) | 2.00 (1.02) | 0.13 |
Denotes statistically significant difference. SD = standard deviation, MVA = motor vehicle accident, MLS = midline shift, GCS = Glasgow Coma Scale, LOS = length of stay.
Characteristics of patients who underwent surgery among both screened and unscreened patients.
| Patient | Age (yrs) | Sex | Antithrombotic | Mechanism | GCS | Bleed | MLS | Surgery | LOS (days) |
|---|---|---|---|---|---|---|---|---|---|
| Screened | 81 | Female | Aspirin | Fall | 14 | SDH | 1 mm | craniotomy | 1 |
| Unscreened | 85 | Male | None | Fall | 15 | SDH | 15 mm | craniotomy | 5 |
| Unscreened | 66 | Male | None | Fall | 15 | SDH | 11 mm | craniotomy | 4 |
| Unscreened | 86 | Female | Aspirin, Plavix | Fall | 14 | SDH | None | craniotomy | 8 |
| Unscreened | 85 | Male | Aspirin | Fall | 15 | SDH | 5 mm | craniotomy | 5 |
| Unscreened | 76 | Female | None | Fall | 15 | SDH | 10 mm | craniotomy | 5 |
| Unscreened | 58 | Male | Aspirin | Fall | 14 | SDH | 12 mm | craniotomy | 5 |
| Unscreened | 78 | Female | Coumadin | Fall | 15 | IVH | None | VPS | 9 |
SDH = subdural hematoma, IVH = intraventricular hemorrhage, GCS = Glasgow Coma Scale, IVH = intraventricular hemorrhage, MLS = midline shift, VPS = ventriculoperitoneal shunt, LOS = length of stay.
Characteristics of patients who were transferred after screening.
| Age (yrs) | Sex | Antithrombotic | Mechanism | GCS | Bleed | MLS | Surgery | LOS (days) |
|---|---|---|---|---|---|---|---|---|
| 78 | Male | None | Fall | 15 | SDH | None | No | 1 |
| 81 | Female | Aspirin | Fall | 14 | SDH | 1 mm | craniotomy | 3 |
| 48 | Female | None | Fall | 15 | SDH | None | No | 0 |
| 61 | Male | Aspirin | Unknown | 15 | tSAH | None | No | 0 |
| 83 | Female | Aspirin, Coumadin | Fall | 15 | SDH | None | No | 1 |
SDH = subdural hematoma, GCS = Glasgow Coma Scale, SDH = subdural hematoma, tSAH = traumatic subarachnoid hemorrhage, MLS = midline shift, LOS = length of stay.
Financial cost of care for all patients.
| Screened (n = 40) | Unscreened (n = 16) | P value | |
|---|---|---|---|
| Direct supply | $3.80 ($19.90) | $333.00 ($544.00) | |
| Pharmacy | $486.00 ($730.00) | $497.00 ($642.00) | 0.66 |
| Blood transfusion | $12.90 ($67.00) | $102.00 ($150.00) | |
| Imaging | $150.00 ($205.00) | $104.00 ($125.00) | 0.31 |
| Laboratory | $57.80 ($45.30) | $119.10 ($89.40) | |
| Floor (non-ICU Ward) | $611.00 ($335.00) | $625.00 ($790.00) | 0.94 |
| ICU | $19.00 ($121.00) | $897.00 ($1581.00) | |
| Emergency room | $170.40 ($34.20) | $178.50 ($67.2) | 0.65 |
| Miscellaneous | $466.00 ($483.00) | $1267.00 ($1415.00) | |
| Total | $2003.00 ($2173.00) | $4482.00 ($1013.00) |
Denotes statistically significant difference.
Financial cost of care for patients that did not have surgical intervention.
| Screened (n = 39) | Unscreened (n = 12) | P value | |
|---|---|---|---|
| Direct supply | $3.80 ($20.10) | $209.00 ($489.00) | 0.17 |
| Pharmacy | $499.00 ($2107.00) | $310.00 ($744.00) | 0.78 |
| Blood transfusion | $13.20 ($67.80) | $95.00 ($149.00) | 0.09 |
| Imaging | $152.00 ($207.00) | $192.00 ($145.00) | 0.41 |
| Laboratory | $57.20 ($45.80) | $85.00 ($57.70) | 0.14 |
| Floor (non-ICU Ward) | $620.00 ($334.00) | $314.00 ($314.00) | |
| ICU | $20.00 ($123.00) | $715.00 ($1300.00) | 0.09 |
| Emergency room | $187.00 ($34.60) | $281.00 ($48.60) | 0.11 |
| Miscellaneous | $473.00 ($488.00) | $736.00 ($847.00) | 0.32 |
| Total | $2025.00 ($2197.00) | $2939.00 ($3252.00) | 0.38 |
Denotes statistically significant difference.